Deutsche Bank
SPRO icon

Deutsche Bank’s Spero Therapeutics SPRO Stock Holding History

Deutsche Bank’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,885
Closed -$121K – 4310
2022
Q1 		$121K Sell
13,885
-1,658
-11% -$17K ﹤0.01% 3507
2021
Q4 		$249K Buy
15,543
+780
+5% +$12.4K ﹤0.01% 3268
2021
Q3 		$272K Sell
14,763
-452
-3% -$7.25K ﹤0.01% 3407
2021
Q2 		$213K Buy
15,215
+1,262
+9% +$17.6K ﹤0.01% 3752
2021
Q1 		$205K Sell
13,953
-1,239
-8% -$21.8K ﹤0.01% 3621
2020
Q4 		$294K Buy
15,192
+6,916
+84% +$108K ﹤0.01% 3238
2020
Q3 		$92K Buy
8,276
+752
+10% +$8.9K ﹤0.01% 3592
2020
Q2 		$102K Buy
7,524
+4,055
+117% +$45.5K ﹤0.01% 3422
2020
Q1 		$28K Sell
3,469
-4,461
-56% -$39.3K ﹤0.01% 3806
2019
Q4 		$76K Buy
7,930
+5,045
+175% +$54.4K ﹤0.01% 3722
2019
Q3 		$30K Sell
2,885
-4,852
-63% -$51.1K ﹤0.01% 4171
2019
Q2 		$88K Sell
7,737
-2,217
-22% -$26.7K ﹤0.01% 4266
2019
Q1 		$127K Sell
9,954
-1,077
-10% -$11.4K ﹤0.01% 4217
2018
Q4 		$67K Sell
11,031
-8,291
-43% -$67.1K ﹤0.01% 4371
2018
Q3 		$203K Buy
19,322
+6,748
+54% +$78.3K ﹤0.01% 4233
2018
Q2 		$184K Buy
12,574
+4,747
+61% +$60.7K ﹤0.01% 4321
2018
Q1 		$110K Sell
7,827
-5,466
-41% -$66.3K ﹤0.01% 4460
2017
Q4 		$155K Buy
+13,293
New +$163K ﹤0.01% 4126

Other funds holding SPRO

ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deutsche Bank's SPRO Position: Q2 2022 in Review

Deutsche Bank sold out of Spero Therapeutics (SPRO) in Q2 2022, closing a stake of 13,885 shares — an estimated $121K sold.

Deutsche Bank first reported a position in SPRO in Q4 2017 and held it in 18 quarters. The position peaked at $294K in Q4 2020. 79 funds tracked by Wall St. Rank hold SPRO as of Q2 2022.

  • Deutsche Bank reported no remaining Spero Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 13,885 Spero Therapeutics shares in Q2 2022, an estimated $121K.
  • Deutsche Bank first reported a position in Spero Therapeutics in Q4 2017 and held it in 18 quarters.
  • Deutsche Bank's Spero Therapeutics position peaked at $294K in Q4 2020.
  • 79 funds tracked by Wall St. Rank held Spero Therapeutics as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.